Mid‐regional pro‐adrenomedullin outperforms N‐terminal pro‐B‐type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation-Reference-Cited by-同舟云学术

Mid‐regional pro‐adrenomedullin outperforms N‐terminal pro‐B‐type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation

Published:2019-12-06 Issue:4 Volume:22 Page:692-700
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Kuan Win Sen¹²,Ibrahim Irwani¹²,Chan Siew Pang³⁴,Li Zisheng¹,Liew Oi Wah³⁴,Frampton Chris⁵,Troughton Richard⁵,Pemberton Chris J.⁵,Chong Jenny Pek Ching³⁴,Tan Li Ling³⁴,Lin Weiqin³⁴,Ooi Shirley Beng Suat¹²,Richards A. Mark³⁴⁵

Affiliation:

1. Emergency Medicine Department National University Hospital, National University Health System Singapore

2. Department of Surgery, Yong Loo Lin School of Medicine National University of Singapore Singapore

3. Cardiovascular Research Institute National University Heart Centre Singapore, National University Health System Singapore

4. Department of Medicine, Yong Loo Lin School of Medicine National University of Singapore Singapore

5. Christchurch Heart Institute University of Otago Christchurch New Zealand

Funder

Health Research Council of New Zealand

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1660

Reference30 articles.

1. Epidemiology and aetiology of heart failure

2. Worldwide Epidemiology of Atrial Fibrillation

3. Comorbidity of atrial fibrillation and heart failure

4. Atrial Fibrillation Begets Heart Failure and Vice Versa

5. Atrial fibrillation in heart failure: what should we do?;Kotecha D;Eur Heart J,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness;International Journal of Cardiology;2024-07

2. Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System;Circulation Research;2023-04-28

3. Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond – major changes are coming;Journal of Cardiovascular Medicine;2022-12

4. Heart failure: an update from the last years and a look at the near future;ESC Heart Failure;2022-12

5. Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke;Brain Pathology;2022-08-02